Phase II is now operational, marking a shift to scale-up and cash flow generation. Q1 saw record harvests, stable costs, and strong biological performance, with significant production and cost improvements expected as phase II ramps up.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.